|
IPSC | Century Therapeutics, Inc. |
|
|
IPSC | Century Therapeutics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 3.19 |
| Leverage | 49.65% |
| Market Cap | $ 61.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -129.1m |
| Margin | -572.00% |
None